Home › Multiple Sclerosis › New Jersey
Multiple Sclerosis clinical trials in New Jersey
11 studies for Multiple Sclerosis are looking for participants at sites in New Jersey.
Cities in New Jersey
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Rutgers Cancer Institute of New Jersey, New Brunswick
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT03816345A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
- TG Therapeutics Investigational Trial Site, Bridgewater
- TG Therapeutics Investigational Trial Site, Cherry Hill
- TG Therapeutics Investigational Trial Site, Freehold
- and 3 more
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT06433752Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
- Holy Name Medical Center- Site Number : 8400101, Teaneck
RecruitingPhase 3
Ages 18 to 60 · All sexes · Updated Sep 15, 2026 · NCT07325292Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
- Local Institution - 0131, New Brunswick
RecruitingPhase 3
Ages 10 to 17 · All sexes · Updated Sep 10, 2026 · NCT06408259A Study Comparing Effectiveness of Kesimpta® (Ofatumumab) Versus Ocrevus® (Ocrelizumab) in Real-world Practice
- Novartis, East Hanover
RecruitingObservational study
Ages 18 to 100 · All sexes · Updated Aug 21, 2026 · NCT07779460A Novel Combinatory Approach to Maximize Functional Recovery of Learning and Memory in Multiple Sclerosis
- Kessler Foundation, East Hanover
Recruiting
Ages 18 to 70 · All sexes · Updated Aug 5, 2026 · NCT06197685Risk of Progressive Multifocal Leukoencephalopathy Among Patients With Multiple Sclerosis Exposed to Zeposia
- Bristol Myers Squibb, Lawrenceville
RecruitingObservational study
All ages · All sexes · Updated Jul 29, 2026 · NCT07732907Silodosin for Urinary Symptoms in Female Patients With Multiple Sclerosis
- Atlantic Health, Morristown
RecruitingPhase 4
Ages 18 and older · Women · Updated May 29, 2026 · NCT07614321Multiple Sclerosis Implementation Network (Registry)
- Multiple Sclerosis Association of America, Cherry Hill
RecruitingObservational study
Ages 18 and older · All sexes · Updated Feb 17, 2026 · NCT07415824Investigating the Effects of Wearable Robotic Exoskeleton for Improving Mobility and Cognition in Persons With MS
- Kessler Foundation, West Orange
Recruiting
Ages 18 to 75 · All sexes · Updated Nov 24, 2025 · NCT04855825Testing the Feasibility of Computer-based Cognitive Training in Individuals with Multiple Sclerosis Living in the Community
- Kessler Foundation, East Hanover
Recruiting
Ages 19 to 65 · All sexes · Updated Feb 21, 2025 · NCT06608797From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.